EUVIMEDEUVIMED entdecken
Open Access

Retrospective analysis of antimicrobial susceptibility profiles of non- diphtheriae Corynebacterium species from a tertiary hospital and reference laboratory, 2012–2023

Ryan B Khodadadi iD, Said El Zein iD, Christina G Rivera O'Connor iD, Ryan W Stevens, Audrey N Schuetz iD, Omar M Abu Saleh, Madiha Fida iD

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.01199-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Ryan B Khodadadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Corynebacterium, Tertiary Care Centers, Microbial Sensitivity Tests, Corynebacterium Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, HHS | NIH | National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A total of 1,925 Corynebacterium isolates were tested for antimicrobial susceptibility at the Mayo Clinic Microbiology laboratory (Rochester, Minnesota) from January 2012 to March 2023, with C. striatum (35.6%) and C. amycolatum (24.4%) identified as the predominant species. Species known to potentially carry diphtheria toxin were excluded. Common sources of isolation included skin and soft tissue (56.8%), bone and/or native joint synovial fluid (14.2%), urine (13.1%), sputum (6.1%), and blood (5.9%). For penicillin, susceptibility decreased from 47.5% (58 of 122) in 2012 to 20.6% (14 of 68) in 2023. Isolates also showed a decrease in susceptibility to erythromycin from 22.4% (26 of 116) in 2012 to 13.2% (9 of 68) in 2023. Susceptibility to trimethoprim-sulfamethoxazole averaged around 50% throughout the period. Notably, linezolid and vancomycin were universally effective in vitro against all species. The highest susceptibility rates among tested oral agents were to linezolid and doxycycline for non- C . striatum species. Daptomycin minimal inhibitory concentrations (MICs) of >256 µg/mL were observed for one C. amycolatum isolate, one C. tuberculostearicum isolate, and for seven C. striatum isolates, all from patients with prior daptomycin exposure. Daptomycin MICs of 2 µg/mL (nonsusceptible) were observed in one C. striatum isolate recovered from a daptomycin-naïve patient and in six C. jeikeium isolates, from both daptomycin-exposed and non-exposed patients. Significant variation in susceptibility profiles across different Corynebacterium species underscores the importance of performing antimicrobial susceptibility testing to guide effective treatment. Moreover, multidrug resistance observed in C. striatum poses substantial therapeutic challenges especially in patients requiring prolonged or chronic antibiotic suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CorynebacteriumTertiary Care CentersMicrobial Sensitivity TestsCorynebacterium InfectionsAnti-Bacterial AgentsHumansRetrospective StudiesFemaleMaleAdultMiddle AgedAgedAdolescentYoung AdultChildChild, PreschoolAged, 80 and overInfantMinnesotaDrug Resistance, Bacterial

Stichwörter der Autor:innen

Corynebacteriumantibioticantimicrobialresistancesusceptibility

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Ryan B Khodadadi, Said El Zein, Christina G Rivera O'Connor, Audrey N Schuetz, Madiha Fida

Förderung

  • NCATS NIH HHS
  • HHS | NIH | National Center for Advancing Translational Sciences

Zitieren

APA

Khodadadi, R. B., El Zein, S., Rivera O'Connor, C. G., Stevens, R. W., Schuetz, A. N., Abu Saleh, O. M., & Fida, M. (2024). Retrospective analysis of antimicrobial susceptibility profiles of non- diphtheriae Corynebacterium species from a tertiary hospital and reference laboratory, 2012–2023. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01199-24

Vancouver

Khodadadi RB, El Zein S, Rivera O'Connor CG, Stevens RW, Schuetz AN, Abu Saleh OM, et al. Retrospective analysis of antimicrobial susceptibility profiles of non- diphtheriae Corynebacterium species from a tertiary hospital and reference laboratory, 2012–2023. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.01199-24

BibTeX
@article{Khodadadi2024,
  author = {Khodadadi, Ryan B and El Zein, Said and Rivera O'Connor, Christina G and Stevens, Ryan W and Schuetz, Audrey N and Abu Saleh, Omar M and Fida, Madiha},
  title = {Retrospective analysis of antimicrobial susceptibility profiles of non- diphtheriae Corynebacterium species from a tertiary hospital and reference laboratory, 2012–2023},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.01199-24}
}
Kostenlos starten →